Under Armour reaches settlement in derivative lawsuits

Under Armour (UA, UAA) has reached a settlement in consolidated derivative lawsuits, agreeing to implement corporate governance measures and receive $8.9 million from insurance proceeds, pending court approval scheduled for August 14, 2025. This settlement aims to resolve disputes and strengthen Under Armour’s corporate governance. Despite recent stock volatility and the absence of full-year 2025 guidance, analysts at UBS and Stifel maintain a Buy rating, while Truist Securities, Morgan Stanley, and BofA Securities have adjusted their price targets due to concerns about turnaround strategies and economic uncertainties.

Analysis

Under Armour has entered into a settlement agreement to resolve consolidated derivative lawsuits, a move that includes the implementation of corporate governance measures for three years and an $8.9 million payment to the company, funded by insurance proceeds, contingent upon final court approval scheduled for August 14, 2025. This development, aimed at resolving disputes and strengthening governance, occurs as InvestingPro data suggests the company appears undervalued based on its Fair Value analysis and possesses a healthy liquidity position, evidenced by a current ratio of 2.1. Despite these potentially positive indicators, Under Armour's stock has demonstrated significant volatility, declining 26.9% over the past six months, although it experienced a recent 6.7% weekly gain. The company's fourth-quarter fiscal results met earnings expectations with increased revenue and gross margin. However, Under Armour faces headwinds from tariffs affecting supply and demand dynamics and has notably refrained from issuing full-year 2025 guidance, contributing to a speculative market tone. Analyst opinions are divergent: UBS and Stifel maintain Buy ratings with price targets of $8 and $10 respectively, citing brand strength and attractive valuation. In contrast, Truist Securities holds a Hold rating ($7 PT) due to concerns about turnaround strategies, Morgan Stanley maintains an Underweight rating ($4 PT) highlighting the absence of FY25 guidance and potential for negative mid-term EPS revisions, and BofA Securities has a Neutral rating ($8 PT), acknowledging short-term challenges but also potential for future margin recovery. The general sentiment surrounding these developments is mildly positive.

Key Decisions for Investors

• Investors should consider the lawsuit settlement as a positive step in reducing legal overhang and improving corporate governance, although the direct financial impact from the settlement itself is modest.
• Evaluate Under Armour's current valuation, noting InvestingPro's suggestion of undervaluation and the company's strong liquidity, against the significant stock volatility evidenced by a 26.9% decline over the past six months.
• Closely monitor for the release of full-year 2025 guidance and any strategic updates on mitigating tariff impacts, as these are critical uncertainties contributing to the mixed analyst outlooks which range from Buy to Underweight.
• Acknowledge the speculative nature of the current situation; while the settlement and certain fundamental aspects are constructive, the lack of forward guidance and persistent tariff challenges warrant a cautious stance until greater clarity on the company's trajectory emerges.